Clin2
NCT07511205Possibly a fitRecruiting

Study of AZD1043 for overweight or obesity

Healthy ParticipantsObesity

Part of Hormones & metabolism clinical trials.

This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
104 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be an adult who is overweight or has obesity, with a BMI between 25 and 39.9 (or 23 and 39.9 if you are Japanese or Chinese).
  • You must weigh at least 110 pounds (50 kilograms).
  • If you are a woman, you must not be able to become pregnant (postmenopausal or surgically sterilized) or have a negative pregnancy test.
  • You must not have any major health problems, liver or kidney disease, or a history of allergies similar to the study drug.
  • You must not have used any weight loss medications (prescription, over-the-counter, or experimental) in the last 3 months.
  • You must not have had severe mental health conditions like psychosis, bipolar disorder, or major depression that were unstable in the past 2 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07290283Recruiting· Phase 1
Testing safety of AZD3974 in healthy volunteers

This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.

Glendale, California
NCT07731139Not yet recruiting· Phase 1
Testing a new medicine for people with obesity

This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.

Lake Forest, California
NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07725809Not yet recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de
NCT07693231Recruiting· Phase 1
Study of BI 3034701 for healthy or overweight Japanese people

This trial tests different doses of a new medicine in healthy Japanese people and those with obesity or overweight. It aims to see how well the body handles the drug and if it is safe.

Fukuoka, Fukuoka
NCT07668401Not yet recruiting· Phase 3
Weight loss study for people in Asia

This study tests a new medicine called Zenagamtide to help people with excess body weight lose weight. It is designed for adults in Asia who do not have diabetes.

Surat, Gujarat

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.